Cardinal Health, Inc. $CAH Shares Sold by Kwmg LLC

Kwmg LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 75,319 shares of the company’s stock after selling 2,295 shares during the quarter. Cardinal Health comprises approximately 1.3% of Kwmg LLC’s portfolio, making the stock its 26th biggest holding. Kwmg LLC’s holdings in Cardinal Health were worth $17,893,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CAH. Norges Bank purchased a new position in shares of Cardinal Health in the 4th quarter valued at about $790,344,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the period. Marshall Wace LLP boosted its holdings in Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after buying an additional 884,648 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Cardinal Health by 7,053.4% during the first quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock worth $158,491,000 after buying an additional 739,553 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after buying an additional 617,775 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. TD Cowen lifted their price target on shares of Cardinal Health from $255.00 to $275.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Weiss Ratings upgraded Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Wednesday. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Morgan Stanley lifted their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Finally, Robert W. Baird set a $248.00 target price on Cardinal Health in a research report on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $251.73.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $236.57 on Friday. The firm’s 50-day moving average is $226.64 and its two-hundred day moving average is $216.23. The company has a market capitalization of $55.41 billion, a PE ratio of 36.17, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $244.87.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.